LCM
AGIO icon

Laurion Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Laurion Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-248,395
Closed -$10.7M – 288
2024
Q2 		$10.7M Sell
248,395
-116,367
-32% -$4.2M 0.13% 108
2024
Q1 		$10.7M Buy
+364,762
New +$9.77M 0.09% 183
2020
Q1 		– Sell
-29,700
Closed -$1.42M – 727
2019
Q4 		$1.42M Buy
+29,700
New +$1.12M 0.01% 510
2016
Q2 		– Sell
-30,000
Closed -$1.22M – 792
2016
Q1 		$1.22M Buy
+30,000
New +$1.28M 0.02% 399
2015
Q1 		– Sell
-1,973
Closed -$221K – 329
2014
Q4 		$221K Buy
+1,973
New +$176K 0.01% 278

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Laurion Capital Management's AGIO Position: Q3 2024 in Review

Laurion Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2024, closing a stake of 248,395 shares — an estimated $10.7M sold.

Laurion Capital Management first reported a position in AGIO in Q4 2014 and held it in 5 quarters. The position peaked at $10.7M in Q2 2024. 207 funds tracked by Wall St. Rank hold AGIO as of Q3 2024.

  • Laurion Capital Management reported no remaining Agios Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Laurion Capital Management sold 248,395 Agios Pharmaceuticals shares in Q3 2024, an estimated $10.7M.
  • Laurion Capital Management first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • Laurion Capital Management's Agios Pharmaceuticals position peaked at $10.7M in Q2 2024.
  • 207 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.